Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 27;14(8):731.
doi: 10.3390/ph14080731.

Free Amino Acid Alterations in Patients with Gynecological and Breast Cancer: A Review

Affiliations
Review

Free Amino Acid Alterations in Patients with Gynecological and Breast Cancer: A Review

Dagmara Pietkiewicz et al. Pharmaceuticals (Basel). .

Abstract

Gynecological and breast cancers still remain a significant health problem worldwide. Diagnostic methods are not sensitive and specific enough to detect the disease at an early stage. During carcinogenesis and tumor progression, the cellular need for DNA and protein synthesis increases leading to changes in the levels of amino acids. An important role of amino acids in many biological pathways, including biosynthesis of proteins, nucleic acids, enzymes, etc., which serve as an energy source and maintain redox balance, has been highlighted in many research articles. The aim of this review is a detailed analysis of the literature on metabolomic studies of gynecology and breast cancers with particular emphasis on alterations in free amino acid profiles. The work includes a brief overview of the metabolomic methodology and types of biological samples used in the studies. Special attention was paid to the possible role of selected amino acids in the carcinogenesis, especially proline and amino acids related to its metabolism. There is a clear need for further research and multiple external validation studies to establish the role of amino acid profiling in diagnosing gynecological and breast cancers.

Keywords: amino acids; breast cancer; gynecological cancers; metabolomics; proline.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The different levels of “omics” research.
Figure 2
Figure 2
Estimated percentage of new cancer cases (a) and cancer deaths (b) worldwide for 2020 [8].
Figure 3
Figure 3
Search terms and strategy.
Figure 4
Figure 4
Algorithm of the literature search for reviewed articles.
Figure 5
Figure 5
The overview on proline metabolism in gynecological cancers. Numbers represent enzymes involved in proline-relation reactions: 1—glutamate dehydrogenase; 2—P5C dehydrogenase; 3—P5C synthase; 4—glutamine synthase; 5—glutaminase; 6—ornithine aminotransferase; 7—proline dehydrogenase/oxidase; 8—P5C reductase; 9—prolidase; TCA, tricarboxylic acid. α-KG—alpha ketoglutarate; Glu—glutamic acid; Gln—glutamine; Gly—glycine; Orn—ornithine; P5C—pyrroline-5-carboxylate; Pro—proline. Created with Biorender.com accessed on 13 July 2021.

References

    1. Louise Gaynor Metabolomics: Personalised Healthcare through Measuring Metabolites? [(accessed on 11 June 2021)]; Available online: https://www.phgfoundation.org/blog/what-is-metabolomics.
    1. Klupczynska A., Derezinski P., Kokot Z.J. Metabolomics in medical sciences—Trends, challenges and perspectives. Acta Pol. Pharm. 2015;72:629–641. - PubMed
    1. Plewa S., Dereziński P., Florczak-Wyspiańska J., Popławska-Domaszewicz K., Kozubski W., Sokół B., Jankowski R., Matysiak J., Kokot Z.J. LC-MS/MS based targeted metabolomics method for analysis of serum and cerebrospinal fluid. J. Med. Sci. 2019;88:12–20. doi: 10.20883/jms.2019.335. - DOI
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Heer E., Harper A., Escandor N., Sung H., McCormack V., Fidler-Benaoudia M.M. Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study. Lancet Glob. Health. 2020;8:e1027–e1037. doi: 10.1016/S2214-109X(20)30215-1. - DOI - PubMed

LinkOut - more resources